Faculty of Clinical Engineering, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
ME Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.
J Med Virol. 2016 Sep;88(9):1628-35. doi: 10.1002/jmv.24513. Epub 2016 Mar 16.
Human herpesvirus 6 (HHV-6) is classified as two distinct species: HHV-6A and B. HHV-6B infection can cause several clinical manifestations in transplant recipients including encephalitis, bone marrow suppression, and pneumonitis. In contrast to HHV-6B, the clinical features of HHV-6A infection remain largely undefined. Herein, we developed a multiplex cycling probe real-time PCR that discriminated between HHV-6A and HHV-6B. The assay was HHV-6-specific and no cross amplification was demonstrated for other herpesviruses. Moreover, the assay had a broad, linear dynamic range of detection between 1 and 10(6) copies of viral DNA. The quantification of HHV-6A DNA was suppressed by an excess amount of HHV-6B DNA (1 × 10(6) copies/tube) in the multiplex PCR assay; however, 1 × 10(6) copies/tube of HHV-6A DNA did not affect the quantification of 1 × 10(4) copies/tube of HHV-6B DNA. To determine the reliability of the assay for analysis of clinical specimens, DNAs extracted from the peripheral blood of hematopoietic stem cell transplant recipients were assayed using our multiplex real-time PCR versus the standard TaqMan PCR. Strong correlations were demonstrated between the two different assay systems for both HHV-6A (R(2) = 0.913) and HHV-6B (R(2) = 0.909). Therefore, our multiplex HHV-6 species-specific cycling probe real-time PCR is useful for evaluating the precise copy numbers of HHV-6A and B in transplant recipients. However, as HHV-6A copy numbers was affected by presence of high copies of HHV-6B DNA (1 × 10(6) copies/tube), it may be difficult to measure precise copy numbers of HHV-6A in inherited chromosomally integrated HHV-6B patient. J. Med. Virol. 88:1628-1635, 2016. © 2016 Wiley Periodicals, Inc.
人类疱疹病毒 6 型(HHV-6)分为两个不同的种:HHV-6A 和 B。HHV-6B 感染可导致移植受者出现多种临床表现,包括脑炎、骨髓抑制和肺炎。与 HHV-6B 不同,HHV-6A 感染的临床特征在很大程度上尚未明确。在此,我们开发了一种区分 HHV-6A 和 HHV-6B 的多重循环探针实时 PCR。该检测方法对 HHV-6 具有特异性,对其他疱疹病毒没有交叉扩增。此外,该检测方法具有广泛的线性检测动态范围,在 1 至 10(6)拷贝的病毒 DNA 之间。在多重 PCR 检测中,过量的 HHV-6B DNA(1×10(6)拷贝/管)会抑制 HHV-6A DNA 的定量;然而,1×10(6)拷贝/管的 HHV-6A DNA 不会影响 1×10(4)拷贝/管的 HHV-6B DNA 的定量。为了确定该检测方法用于分析临床标本的可靠性,我们使用我们的多重实时 PCR 与标准 TaqMan PCR 对造血干细胞移植受者外周血提取的 DNA 进行了检测。两种不同的检测系统均显示出对于 HHV-6A(R(2)=0.913)和 HHV-6B(R(2)=0.909)之间存在很强的相关性。因此,我们的多重 HHV-6 种特异性循环探针实时 PCR 可用于评估移植受者中 HHV-6A 和 B 的精确拷贝数。然而,由于 HHV-6A 拷贝数受到高拷贝数 HHV-6B DNA(1×10(6)拷贝/管)的影响,因此可能难以测量遗传性染色体整合 HHV-6B 患者中 HHV-6A 的精确拷贝数。J. Med. Virol. 88:1628-1635, 2016。©2016 Wiley Periodicals, Inc.